Global Bio-chem Technology Group Company Limited

符号: 0809.HK

HKSE

0.102

HKD

今天的市场价格

  • 0.2024

    市盈率

  • 0.0037

    PEG比率

  • 908.56M

    MRK市值

  • 0.00%

    DIV收益率

Global Bio-chem Technology Group Company Limited (0809-HK) 财务报表

在图表中,您可以看到 的动态默认数字 Global Bio-chem Technology Group Company Limited (0809.HK). 的默认数据。公司收入显示 NaN M 的平均值,即 NaN % 增长率。整个期间的平均毛利润为 NaN M,即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %,等于 NaN % % 整个公司历史的平均增长率.,

资产负债表

深入分析 Global Bio-chem Technology Group Company Limited 的财务轨迹,我们可以看到其平均资产增长率。有趣的是,这一增长率为 ,反映了公司的高点和低点。与季度相比,这一数字调整为. 回顾过去一年,总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000

balance-sheet.row.cash-and-short-term-investments

088.441.821.8
153.3
79.5
135
304.4
896.5
1600.7
514.4
1403.6
1300.5
2255.4
1734.7
1617.9
1509.1
2021.8
1630
2066.4
1243.1
736.1
433
349.8
95.7

balance-sheet.row.short-term-investments

0227.353.987.3
95.5
93.2
77.7
41.3
50
33.3
35.6
93.6
34.1
33.3
0
23.6
-796.9
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

0395.9279.3443.1
787.1
843
1286
1582.4
1322.6
321.3
581.8
1419.3
0
3573.7
1926.8
2320.3
1459.5
1112.6
404.6
497.3
935.6
466.9
383.3
323.8
228.3

balance-sheet.row.inventory

0148.3216.781.4
143.4
369.5
745.5
592.5
539.8
729.4
843.8
3341.6
3645.3
4666.9
4185.2
2599.3
2277.2
1245.8
603.7
522.2
655.2
366.9
258.4
143.3
90.4

balance-sheet.row.other-current-assets

0336.9149.645.4
128.3
151
1804.1
406.2
53.6
2993.3
2819.8
3315
3009.5
1.6
1.9
18.1
58.4
285.7
356.2
9.1
6.8
86.3
53.6
61.6
84.9

balance-sheet.row.total-current-assets

0969.5687.6592.2
1242
1452.9
2684.6
2885.4
2812.5
5323.4
4178.1
8060.1
7955.3
10497.6
8638.8
6555.6
5304.2
4666
2994.4
3095.1
2840.8
1656.2
1128.3
878.5
499.3

balance-sheet.row.property-plant-equipment-net

04220.25158.45886.5
6353.6
6773.7
6561.2
7251.5
6440.8
6307.2
8768.3
9536.6
13569.1
11638.6
9678.1
9110.2
8979.4
7635.8
6376.5
5338.1
3759.8
2401.3
1530.5
1107.1
694.3

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
106.3
344.6
348.4
348.4
348.4
348.4
348.4
360.9
360.9
357
45.4
13.2
0
0
0

balance-sheet.row.intangible-assets

023.83.8
3.8
3.8
579
626.2
579.9
454.6
702.8
818.4
716.3
37.8
27.7
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

023.83.8
3.8
3.8
579
626.2
579.9
454.6
809.1
1162.9
1064.7
386.2
376.1
348.4
348.4
360.9
360.9
357
45.4
13.2
0
0
0

balance-sheet.row.long-term-investments

017.30.20.2
2.2
4.5
0
-937.9
-779.3
494.6
-5.9
-8.9
51.9
161
97.4
70.9
836.9
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

00-0.2-0.2
-2.2
-4.5
0
297.1
134.3
-494.6
1
25.2
91.1
31.1
17.5
16.5
2.2
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

000.20.2
2.2
4.5
0
-297.1
-134.3
0
5.9
8.9
202.2
1036.3
1027.2
908.5
-29.2
734.9
842.4
612.8
198.9
157.8
74.3
42.9
0

balance-sheet.row.total-non-current-assets

04239.65162.35890.5
6359.6
6782
7140.2
7877.7
7020.7
7256.4
9578.3
10724.6
14979
13253.2
11196.3
10454.5
10137.8
8731.6
7579.8
6307.9
4004.1
2572.3
1604.8
1150.1
694.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

05209.15849.96482.7
7601.6
8234.9
9824.8
10763.1
9833.2
12579.8
13756.4
18784.7
22934.3
23750.7
19835.1
17010.1
15442
13397.6
10574.2
9403
6844.9
4228.4
2733.1
2028.6
1193.6

balance-sheet.row.account-payables

0904.21201.51172.2
1358
1551.5
2162.9
1646.9
1543.4
1505.6
2001.1
2225.3
1300.9
1981.5
1519.2
817.4
1058.9
469
240.8
317.1
150.7
92.4
60.1
45.9
74.5

balance-sheet.row.short-term-debt

04637.78152.97503.2
7927.3
6621.3
6127.3
4861.6
3441.1
4592.2
6008.4
4999.1
3403.6
5789.3
4153.1
4474
3416.6
1662.4
3208.8
2733.2
958
514.5
344.8
188.3
243.3

balance-sheet.row.tax-payables

0103.5331.4319.7
301.6
241.1
229
312.8
165
170.3
182.8
164.1
90.8
206.9
84.3
54.2
38.3
14.3
5.8
4.7
13
7.7
19.6
23.6
14.2

balance-sheet.row.long-term-debt-total

0811.80.3941.1
1034.1
2046.6
2842.5
4469
5049.2
4370.7
2682.5
4798.2
4807.1
2309.5
4224.4
2266.4
2123.4
3140.7
741.7
329.5
651.7
618.3
130.9
58.8
296.7

Deferred Revenue Non Current

031.3100.8115.2
120.8
120.3
133.8
150.2
147.1
134
146
209.7
33.1
36.3
36.5
34.2
27.6
27.5
26.5
0
-463.7
-316.8
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

02697.74032.43268.1
2960.2
1970.1
428.4
216.9
1260.4
1556.5
1246.3
1227.3
915.4
206.9
760.9
1257.3
821.6
1132.8
20
20
47.2
8.4
9.8
109.1
39.7

balance-sheet.row.total-non-current-liabilities

0850.4130.91147.9
1258.9
2251
2987
4628.7
5227.3
4731.2
3059.9
5238.2
5116.6
3910.5
4388.3
2422.7
2244.5
3247.3
1018
344.3
668.1
634.6
130.9
261.2
469.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

00.32.24.1
2.2
5.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0924613636.913183.5
13618.7
12580.9
13395.4
13229.6
11637.3
12555.7
12498.5
13689.8
11696.2
11888.2
10162.2
8971.4
7541.5
6511.5
5526.7
4664.4
2221
1415
678.3
604.5
826.6

balance-sheet.row.preferred-stock

001127910257.7
9601.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0890.7890.7890.7
890.7
767.9
639.9
639.9
639.9
639.9
326.3
326.3
326.3
326.2
324.6
231.9
231.9
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

0-9832.2-15203.9-13760.8
-13360
-11251.3
-10183.3
-8967.5
-8128.7
-6282.5
-4564.1
-1190.7
4889.7
5457.8
4283
0
0
46.4
46.4
0
0
0
0
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

02055.23924.93503.1
3758.9
3446
-8985.7
-8983.8
-9433.5
-8947.2
-8777.6
-8038.7
-4330.5
-3644.8
1651.6
-2324
-1852.3
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

02849.3-8429.7-7408.4
-6751.9
2839.5
15081.2
14903.9
15117.6
14442.3
13837.7
13155.7
8784.6
8043.9
2438.8
9574
9008.1
6417.1
5001.1
4738.6
4160.2
2496.7
1854.1
1424
367

balance-sheet.row.total-stockholders-equity

0-4036.9-7539-6517.7
-5861.1
-4197.9
-3447.9
-2407.5
-1804.8
-147.5
822.3
4252.6
9670.2
10183.1
8698.1
7481.9
7387.7
6463.5
5047.5
4738.6
4160.2
2496.7
1854.1
1424
367

balance-sheet.row.total-liabilities-and-stockholders-equity

05209.15849.96482.7
7601.6
8234.9
9824.8
10763.1
9833.2
12579.8
13756.4
18784.7
22934.3
23750.7
19835.1
17010.1
15442
13397.6
10574.2
9403
6844.9
4228.4
2733.1
2028.6
1193.6

balance-sheet.row.minority-interest

00-248.1-183.1
-155.9
-148.1
-122.7
-59
0.7
171.6
435.6
842.3
1568
1679.4
974.8
556.8
512.8
422.6
0
0
463.7
316.8
200.7
0
0

balance-sheet.row.total-equity

0-4036.9-7787.1-6700.8
-6017.1
-4346
-3570.5
-2466.5
-1804.1
24.1
1257.9
5094.9
11238.2
11862.5
9672.9
8038.7
7900.5
6886
5047.5
4738.6
4623.9
2813.5
2054.8
1424
367

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

017.30.20.2
2.2
4.5
77.7
41.3
50
33.3
35.6
93.6
85.9
194.3
97.4
94.5
40
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

05449.58153.28444.3
8961.5
8667.9
8969.8
9330.6
8490.4
8963
8690.9
9797.3
8210.7
8098.8
8377.5
6740.4
5540
4803.1
3950.5
3062.6
1609.7
1132.8
475.7
247.1
540

balance-sheet.row.net-debt

05361.28111.58422.5
8808.1
8588.4
8834.7
9026.3
7593.9
7395.5
8212.1
8487.3
6944.2
5876.7
6642.9
5146.1
4030.9
2781.3
2320.5
996.2
366.6
396.8
42.7
-102.7
444.3

现金流量表

在 Global Bio-chem Technology Group Company Limited 的财务状况中,自由现金流在过去一段时间内发生了显著变化,呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本,与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额,按报告货币计算达到NaN. 与上一年相比, NaN 发生了变化. 在同一时期,公司记录了 NaN, NaN 和 NaN,这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN,同比差异为NaN. 此外,公司还将NaN 用于向股东分红。与此同时,该公司还采取了其他财务措施,即 NaN,这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起,全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000

cash-flows.row.net-income

0-1573.8-409.5-2410.9
-1076.6
-1367.1
-1049
-2082.4
-2265.1
-3712.9
-6019.7
-673.1
1713.9
484
65.3
704.1
979.9
501.2
466.5
815.5
520.8
405.1
330.1
230.2

cash-flows.row.depreciation-and-amortization

0330.5402.5456.9
505
503
419.7
497
612.6
621.3
845.9
667.7
596
524.2
494.9
471.5
362.5
282
221.8
122.1
88.8
63.5
0
0

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
-163
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
26.6
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0413.938.1566.3
816.8
500.1
342.8
-167
577.8
1706
1537.8
1357.3
-489.5
-2196.6
-1177.3
-1009
-993.9
-402.4
999.7
-351.1
-153.6
-201.3
0
0

cash-flows.row.account-receivables

04721.3119.2
310.7
-142.1
-94.3
-113
235.4
553.7
463.4
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-142.136.1243.4
424.9
-125.3
-13.6
99.5
364.9
1820.6
13.8
921.3
-298.9
-1636.2
-373.8
-1101.2
-618.3
-95.6
137.1
-275.4
-108.5
-115.1
0
0

cash-flows.row.account-payables

0114.1-216.3-286
-569.3
629.4
-24.6
138.2
-422.4
-553.7
-463.4
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0394.9197489.7
650.5
138.1
475.3
-291.7
400
-668.3
1060.7
436
-190.6
-560.4
-803.5
92.2
-375.6
-306.9
862.6
-75.6
-45.2
-86.3
0
0

cash-flows.row.other-non-cash-items

0741.4-506.41361.5
-33.9
299.6
553.8
1608.6
790.3
2032.4
4156.2
758.6
534.8
330.8
361.1
365.3
52.2
201.7
159
119.4
80.8
82.3
113.6
-109

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-6.2-25.8-16.8
-51.4
-168.7
-335.5
-169.7
-95
-188.9
-160
-2110.8
-2062.4
-1067.3
-531.3
-1059.5
-998
-1374.2
-1811.3
-1263.4
-671.1
-478.5
-453.8
-144.1

cash-flows.row.acquisitions-net

05.8418.40
-6.1
18
14.6
2.7
66.7
0
-84.4
64.2
-69.7
-203
5.2
-7.1
0
-3.9
0
-93.4
-46.5
0
0
0

cash-flows.row.purchases-of-investments

0000
-0.2
0
0
-2.7
0
0
-58.7
0
-32.1
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
33.3
0
58.7
30.6
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

000136.9
5.3
169.5
0
0
15.3
389.6
340.2
16.5
5.2
27.4
4.4
9.3
7.4
-237
-268.4
-153.2
-8.9
-30.1
-43.4
0

cash-flows.row.net-cash-used-for-investing-activites

0-0.4392.6120.1
-52.5
18.8
-320.9
-133.6
-13.1
259.5
67.7
-2030
-2159
-1242.9
-521.7
-1057.4
-990.6
-1615.1
-2079.6
-1510
-726.6
-508.7
-497.2
-144.1

cash-flows.row.debt-repayment

0-68.9-404.3-365
-3779
-3872.6
-2806.3
-688.7
-4720.7
-5065.3
-3431
-6362.4
-3966.1
-4568.7
-4631.3
-4815.4
-4992.4
-2065.6
-1404.9
-231.4
-487.4
-326.1
-1195.6
-135.7

cash-flows.row.common-stock-issued

000132.7
128
0
0
0
721.2
0
-750
0
0
678.9
0
0
0
0.1
147.8
122.6
88.2
84.7
333.6
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
5689.4
0
0
5644.5
2898.8
2784.8
685.7
1023
554.6
902.7
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
-65
-81.4
-5.5
0
-81.2
-69.6
-58
-160.8
-104.4
-111.6
-70.5
-26.7
-1.7

cash-flows.row.other-financing-activites

0178.7355.6206.4
3387.9
3756.2
2197.6
310.6
5397
3343.7
3496.8
5323.6
4315.8
320.7
5552.2
4814.6
389.3
-241.8
-400.2
838.6
-19.2
-62
424.2
258.6

cash-flows.row.net-cash-used-provided-by-financing-activities

0109.8-48.7-25.9
-263.1
-116.4
-608.7
-378.1
1397.5
-1721.5
-684.2
-1103.8
268.3
2114.8
920.9
-81.9
971.8
533.5
966.7
1311.2
492.9
180.7
438.2
121.3

cash-flows.row.effect-of-forex-changes-on-cash

0-1.4-0.25.8
48.8
-7.2
70.2
-15.4
-11.4
-16
139.7
67.6
159.4
102.5
-2
94.6
9.9
62.6
25.3
0
0
0
-69
-35.3

cash-flows.row.net-change-in-cash

020-131.573.8
-55.5
-169.3
-592.1
-670.9
1088.6
-831.2
43.5
-955.7
487.5
116.8
141.2
-512.7
391.8
-436.4
759.2
507.1
303.1
21.6
315.7
63

cash-flows.row.cash-at-end-of-period

041.821.8153.3
79.5
135
304.4
896.5
1567.4
478.8
1310
1266.5
2222.2
1734.7
1617.9
1509.1
2021.8
1630
2066.4
1243.1
736.1
433
411.4
95.7

cash-flows.row.cash-at-beginning-of-period

021.8153.379.5
135
304.4
896.5
1567.4
478.8
1310
1266.5
2222.2
1734.7
1617.9
1476.7
2021.8
1630
2066.4
1307.2
736.1
433
411.4
95.7
32.7

cash-flows.row.operating-cash-flow

0-88-475.2-26.2
211.3
-64.5
267.3
-143.8
-284.3
646.8
520.3
2110.5
2218.8
-857.6
-255.9
531.9
400.7
582.6
1846.9
705.9
536.7
349.5
443.7
121.2

cash-flows.row.capital-expenditure

0-6.2-25.8-16.8
-51.4
-168.7
-335.5
-169.7
-95
-188.9
-160
-2110.8
-2062.4
-1067.3
-531.3
-1059.5
-998
-1374.2
-1811.3
-1263.4
-671.1
-478.5
-453.8
-144.1

cash-flows.row.free-cash-flow

0-94.2-501-43
159.9
-233.2
-68.3
-313.4
-379.4
457.9
360.3
-0.2
156.4
-1924.9
-787.2
-527.6
-597.3
-791.6
35.6
-557.5
-134.4
-129
-10.1
-22.9

利润表行

Global Bio-chem Technology Group Company Limited 的收入与上期相比变化了 NaN%。据报告, 0809.HK 的毛利润为 NaN。该公司的营业费用为 NaN,与上年相比变化了 NaN%. 折旧和摊销费用为 NaN,与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN,显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN,同比增长NaN%. 营业收入为 NaN,与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000

income-statement-row.row.total-revenue

01373.9372.3746.6
848.9
4561.4
5657.7
4397
3882.8
3352
6399.2
9686.6
11908.1
14438.9
9314.9
7838.3
8810
6796.9
4742.9
4078.9
3375.6
2329.8
1657.3
1385.8
1208

income-statement-row.row.cost-of-revenue

01330.3337.7698.2
774.8
4357.9
5398
3788
3567
3610.6
7288.9
10587.5
10376.1
11071.5
7747.5
6781.8
7059.3
5201.2
3536.2
3027.5
2076.3
1464.9
1006.5
829.5
799.4

income-statement-row.row.gross-profit

043.634.648.4
74.1
203.5
259.7
609
315.8
-258.6
-889.7
-900.9
1532
3367.4
1567.4
1056.5
1750.7
1595.7
1206.8
1051.4
1299.3
865
650.8
556.3
408.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-237.7-1-5.3
-31.3
-37.2
-302.1
-546.1
-1450
-1044.1
-119.1
47.2
-359.6
-16.6
-114.6
-12.6
-142.7
126.8
-203.8
-60.2
-29.5
-26.1
-16.2
-35
-35.9

income-statement-row.row.operating-expenses

0361.8366.9430.9
416.9
811.3
983.5
740.5
575.5
481.3
1578.7
1338.7
1160.3
1143.2
706.1
687.4
687.2
627.6
446
411
27.1
28.5
26.2
20.4
14.9

income-statement-row.row.cost-and-expenses

01692.1704.51129.1
1191.6
5169.2
6381.6
4528.4
4142.5
4091.8
8867.6
11926.2
11536.4
12214.7
8453.6
7469.1
7746.5
5828.8
3982.1
3438.5
2103.3
1493.3
1032.8
849.8
814.3

income-statement-row.row.interest-income

0000.3
0.4
1
4.3
2.6
1.2
12.9
7
4.4
5.7
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

0750.4726.2790.6
724.8
604.1
565
454.7
441.1
515.9
628.3
673.4
585.3
521.9
378.5
307.2
359.4
-126.8
203.8
134
398.3
272.8
183.8
86.3
72.3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

04019.2-724.4564.4
-1446
-98.7
-361.6
-374.1
-1822.7
-2945.6
-7094.4
-11327.3
-584.8
-507
1.2
-303.9
-359.4
126.8
-203.8
-60.2
-29.5
-26.1
-16.2
-35
-35.9

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-237.7-1-5.3
-31.3
-37.2
-302.1
-546.1
-1450
-1044.1
-119.1
47.2
-359.6
-16.6
-114.6
-12.6
-142.7
126.8
-203.8
-60.2
-29.5
-26.1
-16.2
-35
-35.9

income-statement-row.row.total-operating-expenses

04019.2-724.4564.4
-1446
-98.7
-361.6
-374.1
-1822.7
-2945.6
-7094.4
-11327.3
-584.8
-507
1.2
-303.9
-359.4
126.8
-203.8
-60.2
-29.5
-26.1
-16.2
-35
-35.9

income-statement-row.row.interest-expense

0750.4726.2790.6
724.8
604.1
565
454.7
441.1
515.9
628.3
673.4
585.3
521.9
378.5
307.2
359.4
-126.8
203.8
134
398.3
272.8
183.8
86.3
72.3

income-statement-row.row.depreciation-and-amortization

0241.8330.5402.5
456.9
505
503
419.7
497
612.6
621.3
845.9
667.7
596
524.2
494.9
471.5
362.5
282
221.8
122.1
88.8
63.5
96.4
77

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-318.2-849.4-973.8
-964.9
-978
-1005.5
-674.9
141.2
680.5
3381.5
5313
42.7
2220.9
861.3
369.2
1063.6
968.1
760.8
640.4
1018.8
662.4
512.1
439.6
316.7

income-statement-row.row.income-before-tax

03701-1573.8-409.5
-2410.9
-1076.6
-1367.1
-1049
-2082.4
-2265.1
-3712.9
-6014.3
-553.3
1713.9
484
65.3
704.1
1094.8
557
580.2
989.3
636.3
495.8
404.6
280.7

income-statement-row.row.income-tax-expense

0-42.1-54.225.9
22.3
39.7
-67.9
-158.8
-170.1
5.5
58.1
222.6
11.1
336
110.3
51.3
31.3
115
55.7
39.9
58.5
42.9
35.6
23.2
14.2

income-statement-row.row.net-income

04224.6-1519.6-435.4
-2433.3
-1116.3
-1222.3
-837.5
-1850.6
-1996
-3371.4
-6081.1
-554.5
1309.8
331.7
-15
621.8
979.9
501.2
466.5
815.5
520.8
405.1
330.1
230.2

常见问题

什么是 Global Bio-chem Technology Group Company Limited (0809.HK) 总资产是多少?

Global Bio-chem Technology Group Company Limited (0809.HK) 总资产为 5209096000.000.

什么是企业年收入?

年收入为 N/A.

企业利润率是多少?

公司利润率为 0.032.

什么是公司自由现金流?

自由现金流为 -0.017.

什么是企业净利润率?

净利润率为 3.075.

企业总收入是多少?

总收入为 -0.238.

什么是 Global Bio-chem Technology Group Company Limited (0809.HK) 净利润?{{符号}}净利润(净收入)是多少?

净利润(净收入)为 4224593000.000.

公司总债务是多少?

债务总额为 5449538000.000.

营业费用是多少?

运营支出为 361805000.000.

公司现金是多少?

企业现金为 0.000.